Questcor Pharmacueticals, Inc. (Nasdaq QCOR) shares are running higher Thursday following a 48 percent drop Wednesday on Acthar reimbursement concerns.
This article: 192 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE